311 related articles for article (PubMed ID: 16256106)
21. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
[TBL] [Abstract][Full Text] [Related]
22. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
Kamei J; Ohsawa M; Kashiwazaki T; Nagase H
Eur J Pharmacol; 1999 Apr; 370(2):109-16. PubMed ID: 10323258
[TBL] [Abstract][Full Text] [Related]
23. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
24. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse.
Tseng LF; Narita M; Suganuma C; Mizoguchi H; Ohsawa M; Nagase H; Kampine JP
J Pharmacol Exp Ther; 2000 Feb; 292(2):576-83. PubMed ID: 10640294
[TBL] [Abstract][Full Text] [Related]
25. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
26. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
Bhalla S; Zhang Z; Patterson N; Gulati A
Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944
[TBL] [Abstract][Full Text] [Related]
27. Antinociceptive effects of (+)-matrine in mice.
Kamei J; Xiao P; Ohsawa M; Kubo H; Higashiyama K; Takahashi H; Li J; Nagase H; Ohmiya S
Eur J Pharmacol; 1997 Oct; 337(2-3):223-6. PubMed ID: 9430418
[TBL] [Abstract][Full Text] [Related]
28. Agonist and antagonist properties of dihydroetorphine for mu-opioid receptors in mice.
Kamei J; Suzuki T; Nagase H
Neurosci Lett; 1996 Sep; 215(2):87-90. PubMed ID: 8888002
[TBL] [Abstract][Full Text] [Related]
29. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
Jhamandas KH; Sutak M; Henderson G
Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
[TBL] [Abstract][Full Text] [Related]
30. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
31. Effects of diabetes on the morphine-induced Straub tail reaction in mice.
Kamei J; Ohsawa M; Misawa M; Nagase H; Kasuya Y
Neurosci Lett; 1994 Aug; 178(1):66-8. PubMed ID: 7816343
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of morphine tolerance by processed Aconiti tuber is mediated by kappa-opioid receptors.
Shu H; Arita H; Hayashida M; Chiba S; Sekiyama H; Hanaoka K
J Ethnopharmacol; 2006 Jun; 106(2):263-71. PubMed ID: 16446067
[TBL] [Abstract][Full Text] [Related]
33. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
34. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice.
Shu H; Hayashida M; Arita H; Huang W; Zhang H; An K; Wu G; Hanaoka K
J Pharmacol Exp Ther; 2011 Aug; 338(2):579-87. PubMed ID: 21543510
[TBL] [Abstract][Full Text] [Related]
35. Paradoxical hyperalgesia induced by mu-opioid receptor agonist endomorphin-2, but not endomorphin-1, microinjected into the centromedial amygdala of the rat.
Terashvili M; Wu HE; Schwasinger E; Tseng LF
Eur J Pharmacol; 2007 Jan; 554(2-3):137-44. PubMed ID: 17112504
[TBL] [Abstract][Full Text] [Related]
36. Buprenorphine exerts its antinociceptive activity via mu 1-opioid receptors.
Kamei J; Saitoh A; Suzuki T; Misawa M; Nagase H; Kasuya Y
Life Sci; 1995 Mar; 56(15):PL285-90. PubMed ID: 8614238
[TBL] [Abstract][Full Text] [Related]
37. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
[TBL] [Abstract][Full Text] [Related]
38. The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated.
Ross FB; Smith MT
Pain; 1997 Nov; 73(2):151-157. PubMed ID: 9415500
[TBL] [Abstract][Full Text] [Related]
39. Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice.
Anjaneyulu M; Chopra K
Eur J Pharmacol; 2006 May; 538(1-3):80-4. PubMed ID: 16650402
[TBL] [Abstract][Full Text] [Related]
40. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]